EGFR and non-small cell lung carcinoma: In line with data from literature, we showed that RAW 264.7 cells treated with NSCLC exosomes activate EGFR pathway that caused an upregulation of RANKL (Fig. 3) and of osteoclastogenesis markers (MMP9 and TRAP).